Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Hoechst claims bile acid sequestrants

May 10, 1996

Corydalin: ACAT inhibitor from natural source

May 10, 1996

Hoechst claims treatment for chronic polyarthritis

May 10, 1996

New immunosuppressants from Tsumura

May 10, 1996

Bayer claimes quinolones and naphthyridines

May 10, 1996

Fuji Photo Film discloses dermatologic agents

May 10, 1996

HIV protease inhibitors revealed by Warner-Lambert

May 3, 1996

Genistein claimed for menopausal and PMS symptoms

May 3, 1996

Plasmin/kallikrein inhibitors from Hisamitsu

May 3, 1996

Kureha's new agent for renal disorders

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...